Twenty years on: the impact of fragments on drug discovery

Erlanson, Daniel A., Fesik, Stephen W., Hubbard, Roderick E., Jahnke, Wolfgang, Jhoti, Harren·2016·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2016.109

Cited by (1,000)

Items 801–900 of 1,000

  1. Disulfide tethering reveals cryptic pockets in oncogenic KRAS
    Trent E. Balius, Marcin D. Dyba, Vandana Kumari, J. L. Denson, Ming Yi, Alok Kumar Sharma, Priyanka Prakash, Emily O. Alberico, Simon A. J. Messing, Vanessa E. Wall et al. · 2026 · Communications Chemistry
  2. SAFR: Enabling Fragment-Based Drug Discovery with a Synthetic Binding Pose Data Set
    Joan Cabot-March, Xavier Jalencas, Jordi Mestres · 2026 · Journal of Chemical Information and Modeling
  3. Biophysical Sensing Tools in Drug Discovery: Integrating Kinetics, Thermodynamics, Cellular Target Engagement and Structure
    Esra Balıkçı, Caner Akıl · 2026 · Sensors
  4. Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships
    Stéphane Bourg, Matthieu Place, Chloé Copin, A. Chaikuad, Thomas Robert, Hanna Holzmann, Susanne Müller, Stéphane Bach, Sandrine Ruchaud, Stefan Knapp et al. · 2026 · European Journal of Medicinal Chemistry
  5. Developments in the design and therapeutic applications of GSK3β inhibitors
    Safa Daoud, Mutasem O. Taha · 2026 · Future Medicinal Chemistry
  6. In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads
    Ramji Gupta, Pallavi Singh, Karthikeyan Ravi, Mosleh Mohammad Abomughaid, Sorabh Lakhanpal, R. V. Sharma, Nitish Kumar, Niraj Kumar Jha · 2026 · Frontiers in Bioinformatics
  7. Direct Molecular Editing of Complex Molecules for Drug Discovery
    Sidi Cheng, Chunhua Ma, Xiaoyu Chang, Junbiao Chang, Bin Yu · 2026 · Angewandte Chemie International Edition
  8. Fragment and Low Molecular Weight Compound Analysis
    Robert Karlsson, Olof P. Karlsson, Paul E. Belcher · 2017 · Royal Society of Chemistry eBooks
  9. Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections
    Pierfausto Seneci · 2018 · Elsevier eBooks
  10. Imaginative Order from Reasonable Chaos: Conformation-Driven Activity and Reactivity in Exploring Protein–Ligand Interactions
    Alexander F. Moore, David J. Newman, Shoba Ranganathan, Fei Liu · 2018 · Australian Journal of Chemistry
  11. The Application of Fragment-based Approaches to the Discovery of Drugs for Neglected Tropical Diseases
    Christina Spry, Anthony G. Coyne · 2019 · CRC Press eBooks
  12. Application of FMO to Ligand Design: SBDD, FBDD, and Protein–Protein Interaction
    Tomonaga Ozawa, Motoyasu Ozawa · 2021 · Springer eBooks
  13. Protein Docking and Drug Design
    Aditi Gangopadhyay, Hirak Jyoti Chakraborty, Abhijit Datta · 2019 · IGI Global eBooks
  14. Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
    Nicholas R. Vance, Lokesh Gakhar, M. Ashley Spies · 2017 · Angewandte Chemie
  15. Overview of NMR in Drug Design
    David J. Craik, Hayden Peacock · 2018 · Springer eBooks
  16. From Tethered to Freestanding Stabilizers of 14‐3‐3 Protein‐Protein Interactions through Fragment Linking
    Emira J. Visser, Priyadarshini Jaishankar, Eline Sijbesma, Marloes A. M. Pennings, Edmee Vandenboorn, X. Guillory, R. Jeffrey Neitz, John Kenneth Morrow, Shubhankar Dutta, Adam R. Renslo et al. · 2023 · Angewandte Chemie
  17. Extending the Affinity Range of Weak Affinity Chromatography for the Identification of Weak Ligands Targeting Membrane Proteins
    Adrien Deloche, François-Xavier Vidal, Lucile Jammas, Renaud Wagner, Vincent Dugas, Claire Demesmay · 2023 · Molecules
  18. Crystallographic Fragment Screening on the Shigella Type III Secretion System Chaperone IpgC
    Marina Gárdonyi, Christian Hasewinkel, Johanna Wallbaum, J. Wollenhaupt, Manfred S. Weiss, Gerhard Klebe, Klaus Reuter, A. Heine · 2023 · ACS Omega
  19. Lead Generation
    Frank Narjes, Garry Pairaudeau, Dušan Petrović · 2023 · Royal Society of Chemistry eBooks
  20. Screening-Technologien zur Leitstruktursuche
    Gerhard Klebe · 2023 · Springer eBooks
  21. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor
    Yu Jiang, Yingnan Wu, Jing Wang, Yuheng Ma, Hui Lan Yu, Zhanli Wang · 2024 · Current Medicinal Chemistry
  22. Directed Arylation of 7‐Oxabicyclo[2.2.1]heptane to Prepare 3D Fragments
    Max J. Caplin, Imogen M. Alderson, Daniel J. Foley · 2024 · European Journal of Organic Chemistry
  23. Moonlighting Proteins: Importance and Current Scenarios
    Ana Carolina Franco Severo Martelli, Beatriz Brambila, Mariana Pegrucci Barcelos, Flávia da Silva Zandonadi, Solange Cristina Antão, André Vessoni Alexandrino, Carlos Henrique Tomich de Paula da Silva, Maria Teresa Marques Novo‐Mansur · 2024 · Engineering materials
  24. Targeting Mycobacterium tuberculosis F420-dependent dehydrogenases for new anti-tubercular drug discovery
    Adewale Victor Aderemi, M. Snee · 2025 · Indian Journal of Tuberculosis
  25. High-throughput protein crystallography to empower natural product-based drug discovery
    Raphael Meneghello, Joane Kathelen Rodrigues Rustiguel, Evandro Ares de Araújo, Rafael de Felício, Arthur Zanetti N. Fernandes, Éverton L. F. Ferreira, Juliana R. Gubiani, Agnes A. S. Takeda, Amanda Aparecida de Araújo, Caio C. de Lima Silva et al. · 2025 · Acta Crystallographica Section F Structural Biology Communications
  26. Spying on FABPs: characterising protein–ligand interactions with 19F NMR assays
    Evgenia Konstantinidou, Indu R. Chandrashekaran, Menachem J. Gunzburg, Naureen Akhtar, B.C. Doak, Martin J. Scanlon · 2025 · Australian Journal of Chemistry
  27. Impact and Evolution of Biophysics in Medicinal Chemistry
    Michelle Eggen, John F. Schindler · 2017 · Royal Society of Chemistry eBooks
  28. Integration of novel strategy and methods: total synthesis of antitumor lasonolide A
    Lin Yang, Ran Hong · 2019 · Strategies and tactics in organic synthesis
  29. In-Cell NMR Spectroscopy
    Alexander G. Shekhtman, David S. Burz · 2020 · MDPI eBooks
  30. Multi-Omics Data Mining: A Novel Tool for BioBrick Design
    Daniela Burgos-Toro, Martin Dippe, Andrés Felipe Vásquez, Eric Pierschel, Ludger A. Wessjohann, Miguel Fernández‐Niño · 2022 · IntechOpen eBooks
  31. Minimal Increments of Hydrophobic Collapse within the N-Terminus of the Neuropeptide Galanin
    Katelyn N. Kraichely, Sarah E. Clinkscales, Cecilia M. Hendy, Eric A. Mendoza, Stuart R. Parnham, Michael W. Giuliano · 2022 · Biochemistry
  32. Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**
    Jamal El Bakali, Michał Błaszczyk, Joanna C. Evans, Jennifer A. Boland, William J. McCarthy, Imam Fathoni, M.V.B. Dias, Eachan O. Johnson, Anthony G. Coyne, Valerie Mizrahi et al. · 2023 · Angewandte Chemie
  33. Fragment‐Screening und schnelle mikromolare Detektion mit einem Benchtop‐NMR‐Spektrometer ermöglicht durch photoinduzierte Hyperpolarisation
    Gabriela R. Stadler, Takuya F. Segawa, Matthias Bütikofer, Venita Decker, Sandra Loss, Barbara Czarniecki, Felix Torres, Roland Riek · 2023 · Angewandte Chemie
  34. Future Perspectives of Computational Drug Design
    Gisbert Schneider · 2018 · Wiley eBooks
  35. Quantum‐Chemical Analyses of Interactions for Biochemical Applications
    Dmitri G. Fedorov · 2024
  36. Multistep Library Synthesis in Flow: Production of Matrix Libraries in an Assembly Line
    Brenda Pijper, Irini Abdiaj, Javier Mazuela, María Lourdes Linares, José Enrique Gómez, Raquel Rodríguez, Belén Chaves‐Arquero, Eduardo Palao, Santiago Cañellas, Jesús Alcázar · 2024 · ChemRxiv
  37. Does Machine Learning Learn the Physics for Pose Ranking of Fragment-Sized Ligands? A Comparison between Machine Learning and Physics-based Methods
    xiao wan, Bai Xue, Michael A. Bellucci, Zhixiong Lin, Mingjun Yang, Junjie Zou · 2024 · ChemRxiv
  38. Assembly Line Library Synthesis in Flow: A Multistep and Multivectorial Approach
    Brenda Pijper, Irini Abdiaj, Javier Mazuela, María Lourdes Linares, José Enrique Gómez, Raquel Rodríguez, Belén Chaves‐Arquero, Eduardo Palao, Santiago Cañellas, Jesús Alcázar · 2024 · SSRN Electronic Journal
  39. Enhancing the outcome of crystallographic screening for efficient drug discovery by choosing the right crystal form
    Tatjana Barthel, J. Wollenhaupt, Laila S. Benz, Patrick Y. A. Reinke, Linlin Zhang, Melanie Oelker, F. Lennartz, Helena Taberman, U. Müeller, Alke Meents et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Molecular Modeling in Drug Design
    Rebecca C. Wade, Outi M. H. Salo‐Ahen · 2019 · MDPI eBooks
  41. Survival of the Fittest Computational Chemists, Computers, and Reference Works (Over a 30-Year Period)
    Andrew M. Davis, C. Edge · 2017 · Elsevier eBooks
  42. Protein Docking and Drug Design
    Aditi Gangopadhyay, Hirak Jyoti Chakraborty, Abhijit Datta · 2017 · Advances in bioinformatics and biomedical engineering book series
  43. Overview of NMR in Drug Design
    David J. Craik, Hayden Peacock · 2017 · Springer eBooks
  44. Trendbericht Biochemie 2017: Proteinvermittelte dynamische kombinatorische Chemie
    Anna K. H. Hirsch · 2018 · Nachrichten aus der Chemie
  45. Investigating the molecular pharmacology of the short chain fatty acid receptor FFA2
    Eugenia Sergeev · 2018 · Enlighten: Theses (The University of Glasgow)
  46. Step IIIa: Biological Hit Discovery Through High-Throughput Screening (HTS): Random Approaches and Rational Design
    Pierfausto Seneci · 2018 · Elsevier eBooks
  47. MCSS-based Docking and Improved Scoring of Protein-Nucleotide Complexes: I. A step forward to the Fragment-Based Design of Oligonucleotides
    Chevrollier, Nicolas, Fabrice Leclerc · 2019 · HAL Portal Artxiker (Hindustan Aeronautics Limited (India))
  48. Síntese, funcionalização e prospecção biológica de fragmentos heterocíclicos baseados em núcleos heteroaromáticos subexplorados
    Fernando Fumagalli · 2019
  49. Mapeamento das bases estruturais e suas correlações com patogenias humanas associadas à mutações na fumarase humana
    Mariana A. Ajalla Aleixo · 2019
  50. [Serological tests for detection of fungal infection connected with prolonged antibiotic treatment after valve replacement].
    Ewa Orłowska‐Baranowska, Maria Dąbkowska, Irena Rawczynska-Englert · 2002 · PubMed
  51. New Technologies in Drug Development Provide New Hope in Targeting of Dysregulated Redox Signalling in Cardiovascular Disease
    Soloman Saleh, Kristen J. Bubb, Gemma Alexandra Figtree · 2019 · Springer eBooks
  52. Modeling Covalent Protein-Ligand Interactions
    Richard A. Ward · 2019 · Elsevier eBooks
  53. A genome-guided approach to the study of novel secondary metabolites in quarry-derived actinomycetes
    Daryn Fu Ern Tan · 2019
  54. PNA-Encoded Synthesis (PES) and DNA Display of Small Molecule Libraries
    Jacques Saarbach, Jelena Gajić, Sofía Barluenga, Nicolas Winssinger · 2020 · Methods in molecular biology
  55. Síntese e exploração de múltiplos vetores sintéticos em fragmentos \"heteroaromáticos do futuro\"
    Paulo Eliandro da Silva Júnior · 2020
  56. Estudos estruturais e descoberta de ligantes da enzima diidropteroato sintase de Xanthomonas albilineans para o combate da escaldadura das folhas
    Andrew Albert de Oliveira · 2020
  57. Identification of chemical inhibitors for RNase III of Sweet potato chlorotic stunt virus (SPCSV)
    Linping Wang · 2020 · Työväentutkimus Vuosikirja
  58. DNA-encoded Chemistry and Its Use in Discovering Chemical Probes
    Anthony D. Keefe · 2020 · Royal Society of Chemistry eBooks
  59. Structure-based drug discovery aiming at human-diseases related protein targets
    Kai Gao · 2020
  60. Automatic Cavity Identification and Decomposition into Subpockets with CAVIAR
    Jean‐Rémy Marchand, Bernard Pirard, Peter Ertl, Finton Sirockin · 2020 · ChemRxiv
  61. Fragment based drug design: Connecting small substructures for a bioactive lead
    Om Silakari, Pankaj Kumar Singh · 2021 · Elsevier eBooks
  62. Piecing the Fragments Together: Dynamical Insights into the Enhancement of BRD4-BD1 (BET Protein) Druggability in Cancer Chemotherapy Using Novel 8-methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives
    Oluwole B. Akawa, Opeyemi S. Soremekun, Fisayo Andrew Olotu, Mahmoud E. S. Soliman · 2021 · Current Pharmaceutical Biotechnology
  63. Fragment‐Based Lead Discovery
    Roderick E. Hubbard · 2021 · Wiley eBooks
  64. Utility of chemical probes for mass spectrometry based chemical proteomics
    Bekim Bajrami, Jeffrey G. Martin, Douglas S. Johnson · 2021 · Elsevier eBooks
  65. SPECTRe: Substructure Processing, Enumeration, and Comparison Tool Resource: An efficient tool to encode all substructures of molecules represented in SMILES
    Yasemin Yesiltepe, Ryan Scott Renslow, Thomas Metz · 2021 · arXiv (Cornell University)
  66. X-ray crystallographic fragment screening against the human prion protein
    Victor Lopes Rangel · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  67. SAR-by-NMR
    Hartmut Oschkinat, Nestor Kamdem · 2021 · Springer eBooks
  68. Bases estruturais e bioquímicas da interface dimérica essencial da enzima diadenilato ciclase CdaA de Staphylococcus aureus como um novo sítio alostérico de inibição
    Raphael Meneghello · 2021
  69. Automatic Cavity Identification and Decomposition into Subpockets with CAVIAR
    Jean‐Rémy Marchand, Bernard Pirard, Peter Ertl, Finton Sirockin · 2020 · ChemRxiv
  70. Applications of NMR Spectroscopy in FBDD
    M.R. Bentley, B.C. Doak, Biswaranjan Mohanty, Martin J. Scanlon · 2017 · Springer eBooks
  71. Faculty Opinions recommendation of Fragment hits: what do they look like and how do they bind?
    Jane Endicott · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  72. SAR-by-NMR
    Hartmut Oschkinat, Nestor Kamdem · 2021 · Springer eBooks
  73. Faculty Opinions recommendation of Fragment hits: what do they look like and how do they bind?
    John A. Lowe III · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  74. The importance of drug target selection capability for new drug innovation: definition, fostering process, and interaction with organizational management
    Ryo Okuyama, Masaharu Tsujimoto · 2020 · Prometheus
  75. Planejamento de inibidores seletivos de sirtuína 2 de tripanossomatídeos baseado em fragmentos moleculares (FBDD)
    Renan Augusto Gomes · 2021
  76. Busca por candidatos a fármacos contra viroses epidêmicas e pandêmicas, como alvo a RNA-polimerase dependente de RNA (nsP4) do Alfavirus Chikungunya e a papain-like protease (PL-pro) do Betacoronavirus SARS-CoV-2
    M. B. G. dos FREIRE · 2022
  77. Decision: Computational drug discovery under RNA times — R1/PR4
    Mattia Bernetti, Riccardo Aguti, Stefano Bosio · 2022 · QRB Discovery
  78. Decision: Computational drug discovery under RNA times — R2/PR5
    Mattia Bernetti, Riccardo Aguti, Stefano Bosio · 2022 · QRB Discovery
  79. DNA‐ENCODED CHEMICAL LIBRARIES USED FOR DRUG DISCOVERY
    Guixian Zhao, Shilian Yang, Xiaoyu Li, Yizhou Li · 2022 · Wiley eBooks
  80. Decision: Computational drug discovery under RNA times — R0/PR3
    Mattia Bernetti, Riccardo Aguti, Stefano Bosio · 2022 · QRB Discovery
  81. Review: Computational drug discovery under RNA times — R0/PR1
    Mattia Bernetti, Riccardo Aguti, Stefano Bosio · 2022 · QRB Discovery
  82. Review: Computational drug discovery under RNA times — R0/PR2
    Mattia Bernetti, Riccardo Aguti, Stefano Bosio · 2022 · QRB Discovery
  83. Structure of Helicobacter pylori dihydroneopterin aldolase suggests a fragment-based strategy for isozyme-specific inhibitor design
    Gary X. Shaw, Lixin Fan, Scott Cherry, Genbin Shi, Joseph E. Tropea, Xinhua Ji · 2023 · Current Research in Structural Biology
  84. Drug discovery: Standing on the shoulders of giants
    Susan M. Miller, Walter H. Moos, Barbara H. Munk, Stephen A. Munk, Charles P. Hart, David C. Spellmeyer · 2023 · Elsevier eBooks
  85. Application of Fast 2D NMR Methods in the Pharmaceutical Industry
    Kathleen A. Farley, Reto Horst, Martin R. M. Koos, Gregory S. Walker · 2023 · Royal Society of Chemistry eBooks
  86. Pharmaceutical Applications of Organofluorine Compounds. 19 F NMR Fragment‐Based Discovery
    Antonio Misale, Rodrigo J. Carbajo, Jose Maria Cid, Andrés A. Trabanco · 2023 · Patai's chemistry of functional groups
  87. Fortuitous In Vitro Compound Degradation Produces a Tractable Hit against Mycobacterium tuberculosis Dethiobiotin Synthetase: A Cautionary Tale of What Goes In Does Not Always Come Out
    Wanisa Salaemae, Andrew P. Thompson, Birgit I. Gaiser, Kwang Jun Lee, Michael Thomas Huxley, Christopher J. Sumby, Steven W. Polyak, Andrew David Abell, John B. Bruning, Kate L. Wegener · 2023 · ACS Chemical Biology
  88. Catalytic Protein Inhibitors
    Thomas J. Kodadek · 2023 · Angewandte Chemie
  89. Fragment-based Ligand Discovery (FBLD)
    Roderick E. Hubbard · 2023 · Royal Society of Chemistry eBooks
  90. A protein-templated selection approach for the identification of full ligands from DNA-encoded libraries
    2024 · Nature Chemistry
  91. Application of Deep Learning in Materials Design: Extraction of Process-Structure-Property Relationship
    Satoshi F. Noguchi, Hui Wang, Junya Inoue · 2023 · Ouyou toukeigaku
  92. nature inspired and medicinally relevant short peptides
    Maria Gessica Ciulla, Monica Civera, Sara Sattin · 2023 · Vide Leaf, Hyderabad eBooks
  93. Cotranscriptional folding and fragment-based drug discovery of regulatory mRNA
    Albrecht Eduard Völklein · 2024
  94. Light‐Induced Unlocking Reactivity of Fragments for Fast Target‐Guided Synthesis of Carbonic Anhydrase Inhibitors
    Chloé Puteaux, Isabelle Toubia, Lina Truong, Marie Hubert‐Roux, Laëtitia Bailly, Hassan Oulyadi, Pierre‐Yves Renard, Cyrille Sabot · 2024 · Angewandte Chemie
  95. Using Photoreactive Probes to Identify Viable Drug Targets in Non-small Cell Lung Cancer
    Yi Liao · 2024 · Methods in molecular biology
  96. Protocol to perform fragment screening using NMR spectroscopy
    Qiwei Huang, CongBao Kang · 2024 · STAR Protocols
  97. Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments
    Quentin Lefebvre, Raquel Mato, Colin Bournez · 2024 · Synthesis
  98. Assay Development and Screening Strategies for Epigenetic Targets
    Peter J. Brown · 2024 · Royal Society of Chemistry eBooks
  99. Emerging Technologies for Epigenetic Drug Discovery
    2024 · Royal Society of Chemistry eBooks
  100. Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism
    Madeline E. Kavanagh, Kirsty J. McLean, Sophie H. Gilbert, Cecilia Nwadiuto Amadi, M. Snee, Richard B. Tunnicliffe, Kriti Arora, Helena I. Boshoff, Alexander Fanourakis, María José Rebollo-López et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)